Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Dolsten Mikael | Director | May 29 '26 | Sale | 135.42 | 1,600 | 216,672 | 5,548 | Jun 02 04:01 PM |
| Dolsten Mikael | Director | May 29 '26 | Proposed Sale | 135.42 | 1,600 | 216,672 | May 29 04:45 PM | |
| Dolsten Mikael | Director | Dec 01 '25 | Sale | 149.81 | 2,600 | 389,511 | 4,973 | Dec 03 04:04 PM |
| Gonsalves Rodney | V.P., Corporate Controller | Nov 26 '25 | Sale | 154.99 | 3,000 | 464,956 | 31,846 | Dec 01 04:29 PM |
| Dolsten Mikael | Director | Dec 01 '25 | Proposed Sale | 149.81 | 2,600 | 389,510 | Dec 01 04:26 PM | |
| Gonsalves Rodney | Officer | Nov 26 '25 | Proposed Sale | 154.99 | 3,000 | 464,956 | Nov 26 02:26 PM | |
| MCDONNELL PADRAIG | President and CEO | Nov 18 '25 | Sale | 143.24 | 911 | 130,492 | 32,058 | Nov 20 05:22 PM |
| MCDONNELL PADRAIG | Officer | Nov 18 '25 | Proposed Sale | 143.24 | 911 | 130,492 | Nov 18 10:37 AM | |
| MCDONNELL PADRAIG | President and CEO | Nov 12 '25 | Option Exercise | 109.86 | 12,490 | 1,372,151 | 45,938 | Nov 14 04:02 PM |
| MCDONNELL PADRAIG | President and CEO | Nov 12 '25 | Sale | 150.00 | 12,490 | 1,873,500 | 33,448 | Nov 14 04:02 PM |
| MCDONNELL PADRAIG | Officer | Nov 12 '25 | Proposed Sale | 150.00 | 12,490 | 1,873,500 | Nov 12 10:03 AM | |
| McMahon Robert W. | Former Officer | Sep 09 '25 | Proposed Sale | 126.21 | 5,781 | 729,591 | Sep 09 04:26 PM | |
| McMahon Robert W. | Former Officer | Sep 04 '25 | Proposed Sale | 128.62 | 15,303 | 1,968,224 | Sep 04 04:39 PM | |
| MCDONNELL PADRAIG | President and CEO | Sep 02 '25 | Sale | 124.88 | 2,000 | 249,760 | 33,448 | Sep 04 03:36 PM |
| MCDONNELL PADRAIG | Officer | Sep 02 '25 | Proposed Sale | 124.88 | 2,000 | 249,760 | Sep 02 03:30 PM | |
| McMahon Robert W. | Former Officer | Aug 29 '25 | Proposed Sale | 124.96 | 28,081 | 3,508,993 | Aug 29 03:46 PM | |
| Ancher-Jensen Henrik | Former Officer | Aug 29 '25 | Proposed Sale | 125.04 | 21,644 | 2,706,366 | Aug 29 09:59 AM |